Anixa Biosciences Statistics
Share Statistics
Anixa Biosciences has 32.2M
shares outstanding. The number of shares has increased by 0.59%
in one year.
| Shares Outstanding | 32.2M |
| Shares Change (YoY) | 0.59% |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | 18.32% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 8 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 369.67K, so 1.15% of the outstanding
shares have been sold short.
| Short Interest | 369.67K |
| Short % of Shares Out | 1.15% |
| Short % of Float | 1.17% |
| Short Ratio (days to cover) | 5.95 |
Valuation Ratios
The PE ratio is -8.89 and the forward
PE ratio is -7.79.
Anixa Biosciences's PEG ratio is
-0.41.
| PE Ratio | -8.89 |
| Forward PE | -7.79 |
| PS Ratio | 0 |
| Forward PS | 4 |
| PB Ratio | 5.58 |
| P/FCF Ratio | -15.22 |
| PEG Ratio | -0.41 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Anixa Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.54,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.54 |
| Quick Ratio | 8.54 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.03 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,510,800 |
| Employee Count | 5 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 144K |
| Effective Tax Rate | -1.15% |
Stock Price Statistics
The stock price has increased by -5.44% in the
last 52 weeks. The beta is 0.52, so Anixa Biosciences's
price volatility has been higher than the market average.
| Beta | 0.52 |
| 52-Week Price Change | -5.44% |
| 50-Day Moving Average | 2.84 |
| 200-Day Moving Average | 3.01 |
| Relative Strength Index (RSI) | 50.61 |
| Average Volume (20 Days) | 78,709 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.83M |
| Net Income | -12.55M |
| EBITDA | -12.66M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.39 |
Full Income StatementBalance Sheet
The company has 1.27M in cash and 232K in
debt, giving a net cash position of 1.04M.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 232K |
| Net Cash | 1.04M |
| Retained Earnings | -240.75M |
| Total Assets | 18.91M |
| Working Capital | 16.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -7.33M
and capital expenditures 0, giving a free cash flow of -7.33M.
| Operating Cash Flow | -7.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.33M |
| FCF Per Share | -0.23 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
